Annual Interest Expense
N/A
December 31, 2023
Summary
- FATE annual interest expense is not available.
Performance
FATE Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Interest Expense
N/A
September 30, 2024
Summary
- FATE quarterly interest expense is not available.
Performance
FATE Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Interest Expense
N/A
September 30, 2024
Summary
- FATE TTM interest expense is not available.
Performance
FATE TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
FATE Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
FATE Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Fate Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $1.75 M(+3.3%) | $538.00 K(+34.5%) | $1.75 M(+6.6%) |
| Sep 2019 | - | $400.00 K(-2.2%) | $1.64 M(-1.7%) |
| Jun 2019 | - | $409.00 K(+1.0%) | $1.67 M(-0.9%) |
| Mar 2019 | - | $405.00 K(-5.8%) | $1.69 M(-0.4%) |
| Dec 2018 | $1.70 M(+33.8%) | $430.00 K(+0.2%) | $1.70 M(+1.1%) |
| Sep 2018 | - | $429.00 K(+0.9%) | $1.68 M(+3.1%) |
| Jun 2018 | - | $425.00 K(+3.2%) | $1.63 M(+15.1%) |
| Mar 2018 | - | $412.00 K(0.0%) | $1.41 M(+11.5%) |
| Dec 2017 | $1.27 M(-22.5%) | $412.00 K(+9.0%) | $1.27 M(+7.0%) |
| Sep 2017 | - | $378.00 K(+78.3%) | $1.19 M(-0.6%) |
| Jun 2017 | - | $212.00 K(-20.3%) | $1.19 M(-15.8%) |
| Mar 2017 | - | $266.00 K(-19.1%) | $1.42 M(-13.6%) |
| Dec 2016 | $1.64 M | $329.00 K(-14.5%) | $1.64 M(-11.3%) |
| Sep 2016 | - | $385.00 K(-11.5%) | $1.84 M(-8.8%) |
| Jun 2016 | - | $435.00 K(-10.9%) | $2.02 M(-6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $488.00 K(-9.1%) | $2.15 M(-3.2%) |
| Dec 2015 | $2.22 M(+304.4%) | $537.00 K(-4.4%) | $2.22 M(+12.5%) |
| Sep 2015 | - | $562.00 K(-0.2%) | $1.97 M(+23.5%) |
| Jun 2015 | - | $563.00 K(+0.9%) | $1.60 M(+50.3%) |
| Mar 2015 | - | $558.00 K(+91.8%) | $1.06 M(+93.8%) |
| Dec 2014 | $549.00 K(-31.0%) | $291.00 K(+55.6%) | $549.00 K(-13.7%) |
| Sep 2014 | - | $187.00 K(+567.9%) | $636.00 K(-6.3%) |
| Jun 2014 | - | $28.00 K(-34.9%) | $679.00 K(-8.1%) |
| Mar 2014 | - | $43.00 K(-88.6%) | $739.00 K(-7.2%) |
| Dec 2013 | $796.00 K(+63.4%) | $378.00 K(+64.3%) | $796.00 K(+90.4%) |
| Sep 2013 | - | $230.00 K(+161.4%) | $418.00 K(+122.3%) |
| Jun 2013 | - | $88.00 K(-12.0%) | $188.00 K(+88.0%) |
| Mar 2013 | - | $100.00 K | $100.00 K |
| Dec 2012 | $487.00 K(+283.5%) | - | - |
| Dec 2011 | $127.00 K | - | - |
FAQ
- What is the all time high annual interest expense for Fate Therapeutics?
- What is the all time high quarterly interest expense for Fate Therapeutics?
- What is the all time high TTM interest expense for Fate Therapeutics?
What is the all time high annual interest expense for Fate Therapeutics?
Fate Therapeutics all-time high annual interest expense is $2.22 M
What is the all time high quarterly interest expense for Fate Therapeutics?
Fate Therapeutics all-time high quarterly interest expense is $563.00 K
What is the all time high TTM interest expense for Fate Therapeutics?
Fate Therapeutics all-time high TTM interest expense is $2.22 M